Although there are no reports concerning ZRSR2 functions in solid tumors, an increasing number of studies have reported that SR proteins and their specific kinases (SRPKs) as partners to ZRSR2-mediated splicing can have oncogenic effects in several malignancies such as lung cancer, breast cancer and PCa [24–27]. This evidence concerns the gene ZRSR2 and lung carcinoma.